TABLE 1.
Characteristics and responses of 216 persons surveyed about preferred treatments for obsessive-compulsive disorder (OCD), by preferences for first-line and augmentation treatments
First-line treatment (N=198) | Augmentation treatment (N=111) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total (N=216) | Prefers EX/RPa (N=108) | Prefers SRIb (N=90) | Prefers EX/RPa (N=76) | Prefers antipsychotic (N=35) | ||||||
Characteristic | N | % | N | % | N | % | N | % | N | % |
Age (M±SD) | 34±13 | 32±12 | 36±13 | 31±13 | 42±15 | |||||
Female | 157 | 73 | 84 | 78 | 63 | 70 | 63 | 83 | 22 | 63 |
Education | ||||||||||
High school | 17 | 8 | 8 | 7 | 8 | 9 | 5 | 7 | 4 | 11 |
Some college | 79 | 37 | 43 | 40 | 31 | 34 | 29 | 38 | 11 | 31 |
4-year college degree | 120 | 55 | 57 | 53 | 51 | 57 | 42 | 56 | 20 | 57 |
Marital status | ||||||||||
Single | 124 | 59 | 65 | 63 | 48 | 53 | 46 | 60 | 15 | 43 |
Married or living with partner | 75 | 35 | 33 | 32 | 35 | 39 | 22 | 29 | 16 | 46 |
Divorced, separated, or widowed | 12 | 6 | 5 | 5 | 7 | 8 | 5 | 7 | 4 | 11 |
White race | 193 | 89 | 94 | 87 | 88 | 98 | 1 | 1 | 1 | 3 |
Non-Hispanic ethnicity | 197 | 91 | 95 | 88 | 84 | 93 | 69 | 91 | 34 | 97 |
Employment | ||||||||||
Employed | 120 | 53 | 59 | 55 | 55 | 61 | 43 | 57 | 23 | 66 |
Student | 36 | 21 | 17 | 16 | 14 | 16 | 15 | 20 | 2 | 6 |
Unemployed | 60 | 15 | 32 | 30 | 21 | 23 | 18 | 24 | 10 | 29 |
Income | ||||||||||
<$25,000 | 45 | 24 | 25 | 28 | 18 | 21 | 12 | 16 | 6 | 17 |
$25,000-$55,000 | 66 | 35 | 33 | 37 | 30 | 36 | 24 | 32 | 10 | 29 |
$55,001-$85,000 | 29 | 15 | 14 | 16 | 12 | 14 | 13 | 17 | 4 | 11 |
>$85,000 | 49 | 26 | 18 | 20 | 24 | 29 | 13 | 17 | 13 | 37 |
Insurance | ||||||||||
Private | 162 | 75 | 78 | 72 | 71 | 79 | 61 | 80 | 28 | 80 |
Public | 27 | 13 | 15 | 14 | 10 | 11 | 9 | 12 | 15 | 145 |
None | 27 | 12 | 16 | 15 | 9 | 10 | 6 | 8 | 2 | 6 |
Has a diagnosis of OCD | 184 | 85 | 89 | 82 | 80 | 89 | 69 | 91 | 31 | 89 |
OCI-R (M±SD and range)c | 48±14 | 24–84 | 50±15 | 26–84 | 47±13 | 24–76 | 50±15 | 26–84 | 45±11 | 27–72 |
Receiving treatmentd | 124 | 57 | 51 | 47 | 70 | 71* | 68 | 78 | 30 | 86 |
SRIb | 124 | 57 | 47 | 43 | 70 | 78* | 68 | 90 | 30 | 86 |
Benzodiazepine | 30 | 14 | 18 | 17 | 12 | 13 | 18 | 24 | 4 | 11* |
Antipsychotic | 19 | 8 | 8 | 7 | 10 | 11 | 7 | 11 | 9 | 26 |
EX/RPa | 20 | 9 | 13 | 12 | 6 | 7 | 10 | 13 | 2 | 6 |
Cognitive therapy | 67 | 31 | 37 | 34 | 29 | 32 | 32 | 42 | 12 | 34 |
OCD support group | 9 | 4 | 5 | 5 | 4 | 4 | 3 | 4 | 2 | 6 |
Supportive/dynamic therapy | 23 | 11 | 10 | 9 | 12 | 13 | 12 | 16 | 5 | 14 |
Experience with treatment | ||||||||||
Positive overall | 76 | 49 | 32 | 41 | 42 | 58* | 33 | 43 | 13 | 37 |
Positive with medications | 69 | 44 | 20 | 27 | 47 | 61* | 32 | 42 | 15 | 43 |
Positive with therapy | 83 | 57 | 39 | 54 | 41 | 59 | 38 | 50 | 12 | 34 |
Exposure and response prevention
Serotonin reuptake inhibitor
Obsessive-Compulsive Inventory-Revised. Possible scores range from 24 to 84, with higher scores indicating more severe illness.
For variables related to treatment, responses about first-line treatment were received from 198 participants and responses for augmentation treatment were received from 111 participants.
p=.05, for association with first-line and augmentation treatment preferences